EMD Millipore
- Company typePrivate
- Founded2015
- HeadquartersBillerica, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What EMD Millipore does
EMD Millipore operates the Life Science business of Merck KGaA under the MilliporeSigma brand, headquartered in Billerica, Massachusetts, with 10,000+ employees and a global footprint. The company sells a broad portfolio of over 300,000 products and services spanning filtration, water purification, cell culture, protein biology, molecular biology, analytical chemistry, and contract manufacturing and testing. Its offering is organized into six sub-brands — Millipore® (pharma and biopharma products and CTDMO services), Sigma-Aldrich® (lab and production materials), SAFC® (pharma raw materials), Supelco® (analytical products), Milli-Q® (lab water systems), and BioReliance® (contract testing) — covering the full workflow from research through commercial manufacturing.
Revenue is generated through product sales (consumables, reagents, instruments, and water systems priced per unit with volume discounts), contract manufacturing and testing services for pharmaceutical and biopharmaceutical customers, custom synthesis (oligos, peptides, siRNA), and IVD development and manufacturing. Go-to-market is sales-led, combining a global direct sales force for enterprise biopharma accounts, inside sales, the sigmaaldrich.com e-commerce platform for transactional SMB and academic buyers, and the MPartner digital marketplace for custom enterprise orders. Customer segments include pharmaceutical and biopharmaceutical companies, research institutions and academia, industrial and quality control labs, and healthcare and diagnostics providers.
The business was formed through the 2015 merger of Millipore and Sigma-Aldrich under Merck KGaA, and continues to invest in integrated service lines for monoclonal antibodies and mRNA development and manufacturing. In 2026 the company joined an MIT-led NIIMBL-funded consortium with Landmark Bio and Virica Biotech to improve AAV vector production for gene therapy, signalling continued expansion into emerging biopharma modalities.
EMD Millipore firmographics
Firmographics- Name
- EMD Millipore
- Legal name
- EMD Millipore (operating as part of MilliporeSigma, a division of Merck KGaA)
- Website
- https://emdmillipore.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Ownership category
- akta.pro rank
EMD Millipore industry classification
Industry- Product category
- Life Science Tools and Biopharmaceutical Manufacturing Services
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Gene Therapy (Viral Vector/Plasmid) CDMO (HLAGABAE)
- akta.pro secondary industries
- mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI)
Keywords
Where EMD Millipore is headquartered
LocationHeadquarters
- HQ city
- Billerica
- HQ country
- United States
- HQ region
- North America
Markets served
EMD Millipore business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Life Science Products: Sale of broad portfolio of research chemicals, biochemicals, reagents, labware, filtration products, water purification systems and consumables
- Contract Manufacturing: Contract manufacturing services for pharmaceutical and biopharmaceutical companies including mAbs and mRNA development and manufacturing
- Contract Testing Services: BioReliance contract testing services for pharmaceutical quality control and regulatory compliance
- Custom Products: Custom synthesis services including DNA oligos, RNA, siRNA, and custom peptides
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard catalog products with volume discounts |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
EMD Millipore product offering
Product offeringCore offering
EMD Millipore (MilliporeSigma) supplies a broad portfolio of life science products and services for pharmaceutical development and manufacturing, including filtration consumables, lab water purification systems, cell culture media and reagents, protein and molecular biology reagents, analytical chemistry standards, and CTDMO (contract testing, development, and manufacturing) services for mAbs and mRNA biotherapeutics. The company also offers certified reference materials, custom synthesis (DNA/RNA oligos, peptides), IVD development services, and digital life science platforms sold through six sub-brands (Millipore, Sigma-Aldrich, SAFC, Supelco, Milli-Q, BioReliance).
Product overview
EMD Millipore, operating as MilliporeSigma under parent company Merck KGaA, is a diversified life science company offering a broad portfolio of products and services for pharmaceutical development and manufacturing. The company operates through six primary sub-brands: Millipore® (Pharma/BioPharma products and CTDMO services), Sigma-Aldrich® (Lab and production materials), SAFC® (Pharma raw material solutions), Supelco® (Analytical products), Milli-Q® (Lab water solutions), and BioReliance® (Contract testing services). The portfolio spans analytical chemistry, cell culture, filtration, molecular biology, protein biology, mAbs and mRNA development and manufacturing, and water purification. Services include contract manufacturing, contract testing, custom products, digital solutions, and IVD development. The company also participates in public-private partnerships for biopharmaceutical innovation, including NIIMBL consortia for viral vector production improvements.
Differentiator
Problem solved
Functional benefit
Brands
- Millipore®: Expert Pharma / BioPharma Products & CTDMO Services
- Sigma-Aldrich®
- SAFC®
- Supelco®
- Milli-Q®
- BioReliance®
Products and services
- Millipore Pharma and BioPharma Products and CTDMO Services Expert pharma and biopharma products and CTDMO (Contract Testing, Development, and Manufacturing Organization) services for the biopharmaceutical industry.
- Sigma-Aldrich Lab and Production Materials Lab and production materials including chemicals, reagents, certified reference materials, and lab essentials for research and industrial applications.
- SAFC Pharma and Biopharma Raw Material Solutions Pharma and biopharma raw material solutions providing critical ingredients and materials for pharmaceutical manufacturing.
- Supelco Analytical Products Analytical products including chromatography columns, stationary phases, and analytical reagents for laboratory testing and quality control.
- Milli-Q Lab Water Solutions Lab water solutions including water purification systems, consumables, and services for producing ultra-pure water in laboratory environments, with the Milli-Q CLX 8Series addressing clinical lab water needs.
- BioReliance Contract Testing Services Contract testing services providing biosafety testing, characterization, and regulatory compliance testing for biopharmaceutical products.
- mAbs Development and Manufacturing Services Integrated monoclonal antibody development and manufacturing services from cell line development to final drug substance.
- mRNA Development and Manufacturing Services End-to-end mRNA development and manufacturing services including process development, GMP production, and analytics.
- Contract Manufacturing Services Custom manufacturing services for pharmaceutical intermediates, APIs, and complex molecules under GMP conditions.
- Contract Testing Services Comprehensive testing services including biosafety testing, impurity profiling, and regulatory compliance testing.
- Custom Products Services Custom synthesis, custom peptides, custom oligos, and made-to-order chemical products.
- IVD Development and Manufacturing Services In vitro diagnostic product development and manufacturing services for regulatory approval.
- ReCycler Solvent Systems Solvent recycling and returnable container systems that reduce packaging waste and eliminate hazardous disposal costs.
Companies that use EMD Millipore
Customer profileSegments4 records
Ideal customer profiles4 records
EMD Millipore technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
EMD Millipore partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Massachusetts Institute of Technology (MIT)coreMIT-led consortium with EMD Millipore, Landmark Bio, and Virica Biotech focused on improving adeno-associated viral vector production for gene therapy. The project aims to reduce empty viral capsids in collaboration with NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals).
- Landmark BiocorePart of MIT-led consortium working on adeno-associated viral vector production for gene therapy. Landmark Bio contributes to the effort to reduce empty viral capsids in partnership with EMD Millipore.
- Virica BiotechcorePart of MIT-led consortium focused on improving adeno-associated viral vector production. Virica Biotech collaborates with EMD Millipore, Landmark Bio, and MIT to advance gene therapy manufacturing.
- NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals)coreNIIMBL is a U.S. public-private partnership focused on biopharmaceutical manufacturing innovation. EMD Millipore is part of an MIT-led consortium funded by NIIMBL to support domestic viral vector production for gene therapy.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
EMD Millipore competitors and assessment
Company assessmentDirect peers
- Bio-Rad Laboratories: Life science research and clinical diagnostics company offering reagents, instruments, and process chromatography. Competes in protein biology, molecular biology, and bioprocess chromatography.
- Lonza Group: World's largest contract development and manufacturing organization (CDMO) for biologics, cell and gene therapies, and mRNA. Direct competitor in mAbs, mRNA, and gene therapy CDMO services.
- Sartorius: Leading bioprocessing and fermentation supplier with strong filtration and single-use technologies for biopharma manufacturing. Direct peer in upstream/downstream bioprocessing and CDMO enablement.
- Waters Corporation: Specialty analytical instruments and chromatography consumables provider. Competes with Supelco and analytical chemistry product lines in LC, MS, and chromatography.
- Agilent Technologies: Analytical instruments and life science consumables provider competing in chromatography, mass spectrometry, and lab chemicals/reagents within EMD Millipore's analytical chemistry portfolio.
- Charles River Laboratories: Contract research organization providing preclinical, biosafety, and manufacturing support services. Overlaps with BioReliance contract testing and biopharma quality control offerings.
- Danaher (Cytiva): Diversified life science conglomerate owning Cytiva (bioprocessing) and Beckman Coulter (life sciences). Competes directly in bioprocessing consumables, filtration, and CDMO-adjacent services.
- Thermo Fisher Scientific: Largest life science tools and CDMO player globally, offering analytical instruments, reagents, bioprocessing products, and contract manufacturing services (Patheon). Direct competitor across filtration, reagents, analytical, and CDMO.
Emerging players
- Repligen Corporation: Specialty bioprocessing company focused on filtration, chromatography, and process analytics. Emerging direct competitor in bioprocess filtration and CDMO-adjacent consumables.
Broad incumbents
- Eurofins Scientific: Global contract testing services group offering bioanalytical, pharmaceutical, and microbiological testing. Overlaps with BioReliance contract testing and industrial microbiology QC services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
EMD Millipore social profiles
Digital presenceEMD Millipore financial estimates
Financial estimateRevenue estimate
Valuation estimate
EMD Millipore leadership team
Management profileNumber of profiles
Profiles1 record
EMD Millipore funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EMD Millipore M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EMD Millipore
What does EMD Millipore do?
EMD Millipore (MilliporeSigma) supplies a broad portfolio of life science products and services for pharmaceutical development and manufacturing, including filtration consumables, lab water purification systems, cell culture media and reagents, protein and molecular biology reagents, analytical chemistry standards, and CTDMO (contract testing, development, and manufacturing) services for mAbs and mRNA biotherapeutics. The company also offers certified reference materials, custom synthesis (DNA/RNA oligos, peptides), IVD development services, and digital life science platforms sold through six sub-brands (Millipore, Sigma-Aldrich, SAFC, Supelco, Milli-Q, BioReliance).
Is EMD Millipore a public or private company?
EMD Millipore is a private company. It is classified as corporate owned and is currently operating.
When was EMD Millipore founded?
EMD Millipore was founded in 2015. It employs 5,001 to 10,000 people.
Where is EMD Millipore based?
EMD Millipore is headquartered in Billerica, United States, in the North America region.
How does EMD Millipore make money?
Four revenue lines are on record. Life Science Products are the primary driver. The others are contract Manufacturing, contract Testing Services and custom Products.
Who are EMD Millipore's main competitors?
Direct peers on record are Bio-Rad Laboratories, Lonza Group, Sartorius, Waters Corporation, Agilent Technologies, Charles River Laboratories, Danaher (Cytiva) and Thermo Fisher Scientific. Repligen Corporation is listed as an emerging player. Eurofins Scientific is listed as a broad incumbent.
Does EMD Millipore have an API?
No public API is recorded for EMD Millipore.
What industry is EMD Millipore in?
EMD Millipore's product category is Life Science Tools and Biopharmaceutical Manufacturing Services. Its primary akta.pro industry code is HLAGABAE, Gene Therapy (Viral Vector/Plasmid) CDMO, with a secondary code of HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA). Its NAICS code is 3254 and its SIC code is 8731.